FDA Inspection 1223673 — Regenerative Biologics Inc
The FDA completed an inspection of Regenerative Biologics Inc on Nov 16, 2023 in Greenville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Greenville, SC (United States)